Published in Hepatitis Weekly, March 1st, 1999
Sixty months after the initial vaccination, all vaccinees who received annual follow-up still had protective levels of anti-HAV.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.